Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:approvalYear |
2023-02-17
|
| gptkbp:ATCCode |
S01XA25
|
| gptkbp:chemicalClass |
peptide
|
| gptkbp:developer |
gptkb:Apellis_Pharmaceuticals
|
| gptkbp:form |
solution for injection
single-use vial |
| gptkbp:genericName |
gptkb:pegcetacoplan
|
| https://www.w3.org/2000/01/rdf-schema#label |
Syfovre
|
| gptkbp:indication |
gptkb:geographic_atrophy
age-related macular degeneration |
| gptkbp:legalStatus |
prescription only
|
| gptkbp:marketedAs |
gptkb:Apellis_Pharmaceuticals
|
| gptkbp:mechanismOfAction |
complement C3 inhibitor
|
| gptkbp:pregnancyCategory |
not assigned
|
| gptkbp:routeOfAdministration |
intravitreal injection
|
| gptkbp:sideEffect |
ocular inflammation
endophthalmitis retinal artery occlusion retinal vasculitis |
| gptkbp:target |
gptkb:complement_protein_C3
|
| gptkbp:bfsParent |
gptkb:Apellis_Pharmaceuticals
|
| gptkbp:bfsLayer |
7
|